Medical Condition News

RSS

Using symptom dimensions may provide more precise, personalized mental health care

A researcher from the University of Kansas has led a large-scale study of university undergraduates to better understand how psychological conditions such as depression, anxiety, post-traumatic stress disorder and eating disorders are connected.

4 May 2026

AI and polarized light improve early detection of keratoconus

Keratoconus is a progressive eye disease that weakens and thins the cornea, the clear front surface of the eye. In its early, subclinical stage, the cornea can still appear normal on routine exams.

4 May 2026

New research identifies stress response as trigger for heart inflammation

After a heart attack, the body rapidly floods the injured heart with neutrophils - white blood cells that help repair damage but can also make it worse when too many arrive too quickly.

4 May 2026

New technique uses electronic jolt and nanoparticles to reveal early signs of pancreatic cancer

Scientists at Oregon Health & Science University have developed a new technique using an electronic jolt and nanoparticles to reveal the telltale signal of an insidious form of cancer.

4 May 2026

Learn B.E. F.A.S.T. to recognize stroke signs and save lives

A stroke can change a life in an instant. In the minutes after symptoms begin, quick action can help protect the brain, reduce long-term disability and save a life, according to the American Stroke Association, a division of the American Heart Association.

4 May 2026

A more accurate tool for assessing Arsenic toxicity

Public health experts estimate that more than 200 million people worldwide are exposed to arsenic through contaminated drinking water. Scientists know long-term exposure to arsenic is associated with increased risk of chronic illnesses like cancer and cardiovascular disease, but there hasn't been a reliable way to track these exposures and fully understand their effects on the body and the mechanisms behind them.

4 May 2026

Finding new ways to mimic ketamine’s antidepressant effects

Weill Cornell Medicine investigators have "reverse engineered" ketamine's antidepressant effects to identify potential new strategies for treating depression.

4 May 2026

Sickle cell disease care is unevenly distributed across regions in New York State

Sickle cell disease (SCD) is the most common inherited blood disorder in the United States. Approximately 10 percent of people with SCD in the US live in New York State, with the majority residing in New York City.

4 May 2026

New Canadian guidelines streamline screening for high-risk drinking

An update to Canadian guidance on screening for high-risk drinking and alcohol use provides streamlined recommendations in CMAJ (Canadian Medical Association Journal) that authors hope will make it easier for health care professionals to talk to patients about alcohol use.

4 May 2026

Active brown fat may protect heart health in obese individuals

People with obesity face a significantly increased risk of atherosclerosis, and consequently heart attack and stroke.

4 May 2026

High-intensity interval exercise is most effective for heart patients

Endothelial dysfunction is a hallmark of cardiovascular disease (CVD) and plays a central role in vascular inflammation, thrombosis, and impaired vasodilation.

4 May 2026

Cellular aging in immune cells signals early onset of cognitive depression

Blood tests measuring the aging of certain white blood cells can predict cognitive and mood-related symptoms of depression, rather than physical symptoms.

4 May 2026

Researchers leverage tamoxifen's active metabolite to improve breast cancer prevention

Low doses of the investigational medicinal product endoxifen reduce breast density to the same extent as the standard treatment tamoxifen, but without causing such troublesome side effects. This is shown by a new study from Karolinska Institutet published in the Journal of the National Cancer Institute. The results may have implications for future preventive treatment of breast cancer.

4 May 2026

65 % of eligible lung cancer patients do not receive the most appropriate targeted therapies, Diaceutics report finds

Diaceutics, the intelligence and engagement company unlocking the full potential of diagnostic-driven therapies, has released new research revealing a critical shift in precision medicine. Despite major advances in biomarker testing, nearly two-thirds of eligible patients with advanced non-small cell lung cancer (aNSCLC) in the US are still not receiving the most appropriate treatment

From Diaceutics PLC 4 May 2026

AAD survey reveals Americans ignore sun risks despite skin cancer concerns

The American Academy of Dermatology (AAD) today released results from its annual Practice Safe Sun Survey, revealing many Americans still engage in risky sun behaviors driven by misinformation, social media, and persistent tanning myths despite their concerns about the long term aging effects of sun exposure. In recognition of Skin Cancer Awareness Month (May) and Melanoma Monday® on May 4, the AAD is encouraging the public to practice safe sun to reduce their risk of skin cancer.

4 May 2026

Manuka honey eye drops outperform artificial tears for dry eye relief

A clinical study reveals Manuka honey eye drops significantly improve dry eye symptoms after cataract surgery, outperforming traditional treatments.

1 May 2026

Identifying the ages when Alzheimer’s biomarkers sharply change

New research identifies critical ages for Alzheimer's biomarkers, enhancing screening strategies and understanding neurodegeneration across the aging spectrum.

1 May 2026

How fast your face ages may predict cancer survival outcomes

The study links facial aging rates to cancer outcomes, suggesting a new prognostic tool that could personalize treatment and enhance patient survival.

1 May 2026

New genetic risk report reveals hidden heart disease risk before symptoms appear

Researchers developed and externally validated integrated polygenic risk scores for eight cardiovascular conditions using large U.S.-based biobank data. The clinically orderable report may help identify inherited cardiovascular risk that traditional clinical markers can miss, although broader prospective validation is still needed.

30 Apr 2026

GLP-1 drugs reduce risk of major adverse cardiovascular events

New research has shown that GLP‑1 weight-loss drugs deliver protection against heart attacks, strokes and premature death over a sustained period of time.

30 Apr 2026